Synageva BioPharma (GEVA) Announces $80M Common Offering
Synageva BioPharma Corp. (“Synageva”) (NASDAQ: GEVA), has commenced a $80 million underwritten public offering of shares of its common stock. In connection with this offering, Synageva expects to grant to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. Morgan Stanley and J.P. Morgan are acting as joint book-running managers in the offering, and Cowen and Company is acting as co-manager in the offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Notable Analyst Rating Changes 2/11: (TWX) (BDX) (LVLT) Upgraded; (V) (SEMI) (ARMH) Downgraded
- Milestone Scientific, Inc. (MLSS) Files $30M Mixed Shelf
- Morgan Stanley Downgrades Regions Financial (RF) to Equalweight
Create E-mail Alert Related CategoriesEquity Offerings
Related EntitiesJPMorgan, Morgan Stanley, Cowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!